ArticleBMC endocrine disorders2026
Temporal and geographic trends in HbA1c results in South Africa: a retrospective NHLS analysis (2019-2024).
Article in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetes mellitus is a major public health challenge in South Africa, and poor glycaemic control contributes substantially to diabetes-related morbidity and mortality. National data describing temporal trends and geographic variation in HbA1c results within the public healthcare sector remain limited.
methodsWe conducted a retrospective cross-sectional analysis of routinely collected HbA1c test results from the National Health Laboratory Service between 1 January 2019 and 31 December 2024. Adults aged ≥ 18 years with valid sex and plausible HbA1c values (3.5-20.0%) were included. Very high HbA1c was defined as ≥9%. Temporal trends and geographic variation were examined descriptively, and multivariable binary logistic regression was used to identify independent predictors of HbA1c ≥ 9%.
resultsA total of 5,487,887 HbA1c test results were analysed. The mean age was 55.97 years (SD 14.73), and 64.5% of tests were from women. Overall, a substantial proportion of HbA1c results were in the very high range (≥9%), declining from 56.9% in 2019 to 36.3% in 2024 among adults undergoing testing in the public healthcare sector, indicating a shift in HbA1c distributions among individuals undergoing testing. Marked geographic variation was observed across provinces. In multivariable analysis, higher odds of HbA1c ≥ 9% were independently associated with male sex, older age (with peak risk in adults aged 45-59 years), province of testing, point-of-care HbA1c testing, and earlier calendar period.
conclusionsDespite modest improvements over time, very high HbA1c levels remain common among adults undergoing testing in South Africa's public healthcare sector. Persistent geographic and demographic disparities highlight the need for targeted, system-level interventions. Routine laboratory data provide a valuable platform for national surveillance and performance monitoring of glycaemic control. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.